PRQR

ProQR Therapeutics (PRQR)

About ProQR Therapeutics (PRQR)

ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J. Platenburg, Henri A. Termeer, and Domenico Valerio on February 21, 2012, and is headquartered in Leiden, the Netherlands.

Details

Daily high

$2.25

Daily low

$2.03

Price at open

$2.08

52 Week High

$3.10

52 Week Low

$1.07

Market cap

232.5M

Dividend yield

0.00%

Volume

797,886

Avg. volume

645,329

P/E ratio

-4.84

ProQR Therapeutics News